John Peter Gutfreund, Director at Oncocyte Corp (OCX), bought 35,000 shares at $0.93 ($23K) on 2022-08-15, disclosed to the SEC on 2022-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,000 | $0 | 0.0% |
| 2 | $0.93 | 25,000 | $23K | 100.0% |
| Total | $0.66 avg | 35,000 | $23K | 100% |